Editorial
 THREAT OF API AVAILABILITY   
 Thursday, August 17, 2017 
 India’s main worry today should be the danger China can pose to the domestic pharmaceutical production as the trouble in the Indo-China border is only escalating. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Cellectis doses first patient with BPDCN in phase I study of UCART123
17:00  [IST]Seattle Sperm Bank introduces comprehensive genetic testing search tool
16:00  [IST]US FDA's OOPD awards $403,000 grant to Protalex to foster clinical development of Prtx-100 for ITP treatment
15:00  [IST]Medivir licenses rights to develop, manufacture & commercialise MIV-802 for Greater China to Ascletis
14:00  [IST]NIH herpesvirus study in mice leads to discovery of potential broad-spectrum antiviral
13:00  [IST]Mylan finalises $465 mn settlement agreement on Medicaid rebate classification for EpiPen Auto-Injector with US DOJ
more news >>
TOP NEWS
08:00  [IST]Pending PIL related to crosspathy to see the light of the day as MMC to take up crosspathy cases soon
08:00  [IST]Karnataka drugs control dept seizes 62 not-of-standard quality drugs during surprise inspection drive in July
08:00  [IST]AMTZ signs MoU with IIT Bombay to boost innovation in medical device industry
08:00  [IST]TS govt to appoint specialist doctors in PHCs & CHCs to provide highest quality healthcare services to poor patients
08:00  [IST]DIA India to hold seminar on risk-based monitoring from Sept 22- 23 in Mumbai
08:00  [IST]KDPMA welcomes draft pharma policy; alarmed over closure of loan licensing manufacturing, mandatory BE/BA tests, etc
more news >>
YESTERDAY'S NEWS
18:00  [IST]CAEK inks agreement with Henry Schein to distribute HIPAA software, LayerCompliance
17:00  [IST]Lion TCR receives two US FDA orphan drug designations for its T cell therapy products for HCC treatment
16:30  [IST]KDPMA elections reinstate Sunil Attavar as president & Harish K Jain as secretary
16:00  [IST]Scientists give star treatment to lesser-known cells crucial for brain development
15:00  [IST]Iovance Biotherapeutics begins dosing of patients in C-145-04 phase 2 trial of LN-145 to treat cervical cancer
14:15  [IST]Zydus gets US FDA approval for telmisartan & hydrochlorothiazide tablets to treat hypertension
more news >>
INTERVIEW  
New stent pricing to help improve top and bottom lines
Swaminathan Jayaraman, Chairman and Managing Director,
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the Union Health Ministry’s proposal to amend DC Rules to make only registered pharmacists eligible for wholesale licenses justified ?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
IPJPI_150x60en_2017
CPhI-WWW-150x60-stat-v1
IPJPI_150x60en_2017
chemspec2017
cphikorea_150x60_k
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |